Track topics on Twitter Track topics that are important to you
Eyenovia, a startup that has adapted an inkjet printing technique into a way to deliver drugs to the eye, is providing more clarity on an initial public offering intended to finance late-stage clinica...
An initial public offering of 2.73 million shares was priced by New York-based startup Eyenovia at $10 to $12 each. -More-
An initial public offering could pull in up to $35 million for New York-based Eyenovia, which offers piezoelectric dispensati -More-
Ophthalmic-focused Eyenovia Inc. filed for its initial public offering.
Eyenovia has filed an initial public offering to raise money to advance its micro-dosing technology, according to paperwork filed with the Securities and Exchange Commission.The emerging company looks...
Eyenovia will commence in 2019 a late-stage study of MicroPine, a microtherapeutic formulation of atropine, in patients with -More-
Eyenovia has closed its initial public offering of 2.73 million shares of its common stock, according to a press release.Gross proceeds from the offering, before underwriting discounts and commissions...
Ophthalmic-focused Eyenovia Inc. netted $25.4mm through its initial public offering of 2.73mm common shares at $10 each.
This study is to evaluate the usability and patient tolerability for microtherapeutic dosing of commercially available ocular medication via the Eyenovia microdose delivery system (MiDD)
Eyenovia is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for mic...
We have published hundreds of Eyenovia Inc. news stories on BioPortfolio along with dozens of Eyenovia Inc. Clinical Trials and PubMed Articles about Eyenovia Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eyenovia Inc. Companies in our database. You can also find out about relevant Eyenovia Inc. Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...